Hem › Leukemi › Ohio › Columbus
Kliniska studier för Leukemi i Columbus, OH
12 studier för Leukemi söker deltagare vid platser i och runt Columbus (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekryterarFas 3
- Quetzal Site 8, Columbus
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekryterarFas 1/2
- Ohio State University, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
RekryterarFas 2
- Ohio State University Comprehensive Cancer Center, Columbus
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekryterarFas 3
- Ohio State University, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekryterarFas 1/2
- The Ohio State University Wexner Medical Center, Columbus
Hairy Cell Leukemia Patient Data Registry
RekryterarObservationsstudie
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RekryterarFas 1/2
- Dren Investigational Site, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekryterarFas 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RekryterarFas 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekryterarFas 1
- The James Cancer Hospital and Solove Research Institute, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RekryterarFas 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Leukemi-studier i andra städer
- Houston, TX28 studier
- Boston, MA25 studier
- New York City, NY19 studier
- Los Angeles, CA16 studier
- Chicago, IL16 studier
- Durham, NC13 studier
- Baldwin Park, CA12 studier
- Nashville, TN12 studier
- Philadelphia, PA12 studier
- Milwaukee, WI11 studier
- Atlanta, GA11 studier
- Seattle, WA11 studier
Andra studier i Columbus
- Icke-småcellig lungcancer56 studier
- Bröstcancer39 studier
- Äggstockscancer39 studier
- Cancer (alla typer)38 studier
- Lungcancer37 studier
- Akut myeloid leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastaserande cancer27 studier
- Endometriecancer25 studier
- Kolorektal cancer24 studier
- Prostatacancer24 studier
- Multipelt myelom24 studier
Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.